7[3]Balkau B, Charles MA. Comments on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance. Diabetic Med 1999; 16:442
10[17]Itoh, T., Mitsuma, T., Shimada, Y., et al. Importance of the concept of the hypofuction of "Kidney" in treating aged patients. J. Jap. Soc. Oriental Medicine 47(4) :532-538, 1997.
3Gaddam KK, Ventura HO, Lavie CJ. Metabolic syndrome and heart failure - the risk, paradox, and treatment[J]. Curr Hypertens Rep, 2011,13(2) : 142-148.
4Panchal SK, Brown L. Rodent models for metabolic syndrome research[J]. J Biomed Biotechnol, 2011,10( 11 ) : 1-12.
5Sutherland LN, Capozzi LC, Turchinsky NJ, et al. Time course of high-fat dietinduced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance [ J ]. Am J Physiol Endocrinol Metab, 2008, 295 (5) : 1076-1083.
6Lim JS, Mietus-Snyder M, Valente A, et al. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome[J]. Nat Rev Gastroenterol Hepatol,2010,7(5) :251-264.
7Day CP. Non-alcoholic fatty liver disease: a massive problem [J]. Clin Med,2011,11(2) : 176-178.
8Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. Bile acids as regulators of hepatic lipid and glucose metabolism[J]. Dig Dis,2010,28(1) :220-224.
